Life Sciences

FDA releases updated draft guidance for ANA test systems

Device Regulation Alert: Safety, Compliance and Reimbursement News, February 9, 2009

New developments for in vitro diagnostic devices prompted the FDA to release a revised guidance document, “Recommendations for Anti-Nuclear Antibody (ANA) Test System Premarket (510(k)) Submissions.”

Post a Comment





Please enter your comment below:


Please enter the text below:


Most Popular